Oxycodone Does Not Increase Risk for Persistent Opioid Use After Delivery
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, July 31, 2023 -- Initiation of oxycodone versus codeine is not associated with an increased risk for persistent opioid use after delivery overall, but increased risk is seen after vaginal delivery, according to a study published online July 31 in CMAJ, the journal of the Canadian Medical Association.
Jonathan S. Zipursky, M.D., Ph.D., from the Sunnybrook Health Sciences Centre in Toronto, and colleagues conducted a population-based cohort study involving people who filled a prescription for codeine or oxycodone within seven days of hospital discharge after delivery between Sept. 1, 2012, and June 30, 2020. The primary outcome was persistent opioid use, for which the risk was compared for those who initiated oxycodone versus codeine.
A total of 70,607 people who filled an opioid prescription within seven days of discharge were identified during the eight-year study period: 21,308 and 49,299 (30.2 and 69.8 percent) received codeine and oxycodone, respectively. Receipt of oxycodone was not associated with persistent opioid use compared with receipt of codeine (relative risk, 1.04; 95 percent confidence interval, 0.91 to 1.20). After vaginal delivery, there was an association noted between oxycodone and persistent use (relative risk, 1.63; 95 percent confidence interval, 1.31 to 2.03), but this was not seen after cesarean delivery (relative risk, 0.85; 95 percent confidence interval, 0.73 to 1.00).
"Awareness of these factors and others related to persistent use may help clinicians tailor opioid prescribing while ensuring adequate analgesia after delivery," the authors write.
Several authors disclosed ties to biopharmaceutical companies; several authors receive payment for expert testimony or providing medicolegal opinions relating to analgesics.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Considerable Gaps Seen in Provision of Effective Treatment for Opioid Addiction
TUESDAY, July 16, 2024 -- There are considerable gaps in provision of effective treatments for opioid use disorders (OUD) at U.S. substance use disorder (SUD) treatment...
Soy Consumption in Children Tied to Better Thinking, Attention
TUESDAY, July 16, 2024 -- School-aged children who consume more soy foods may have improved thinking and attention, according to a study presented during NUTRITION 2024, the...
Total Dietary Quality Score Improved for U.S. Children During 2005 to 2020
MONDAY, July 15, 2024 -- Total dietary scores improved for U.S. children during 2005 to 2020, with increases for all diet adequacy components, apart from dairy, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.